| |
|
Integrated Efficacy and Safety of Glecaprevir/Pibrentasvir
in Patients With Psychiatric Disorders
|
| |
| |
Reported by Jules Levin
Internati onal Network on Hepatitis Care in Substance Users, 7th International Symposium, 19-21 September 2018, Lisbon, Portugal
David Back1, Pamela Belperio2, Mark Bondin3, Francesco Negro4, Andrew H Talal5, Caroline Park3,
Yang Lei3, Brett Pinksy3, Eric Crown3, Federico Mensa3, Fiona Marra1
1University of Liverpool, Liverpool, United Kingdom; 2US Department of Veterans Aff airs, VA Palo Alto Healthcare System, Palo Alto, California, United States; 3AbbVie Inc., North Chicago, Illinois, United States; 4University of Geneva, Geneva, Switzerland; 5Jacobs School of Medicine and Biomedical Sciences, University of Buff alo, Buff alo, New York, United States
| |
| |
| |
|
|
|
